WP4 will be carried out by the core design team, consisting of three research institutions and two SMEs specialized in service design in health care, with clinical partners. WP4 will follow an iterative process using design thinking techniques and design research, further developing the Metro Mapping methodology for use in breast and prostate cancer and melanoma, in heterogeneous healthcare systems.
work package 4 tasks
Metro Mapping training
During this task, all design partners will be trained in Metro Mapping by the Panton who have developed this methodology for the Dutch context. The main objective of this task is to make sure that the Metro Mapping method is applied in a similar way, allowing adequate further comparisons between services from different countries. This task will begin with an in-person training, followed by e-learnings to be continuously updated and used during the development of WP4, as training in each application of the methodology and advising the teams is considered
a continuous process. The in-person training sessions will be two days.
Extending Metro Mapping
This task will focus on further extending the MetroMapping method incorporating the insights and prognostic tools from WP2 and conversation tool from WP3. It will further facilitate the international application by input from the research institutions and design partners from The Netherlands, Spain, and Denmark.
Further development and research of Metro Mapping methodology
We will redesign care paths in hospitals in The Netherlands, Spain and Denmark in two care paths each. In all countries, ethical approval will be obtained from the Institutional Review Boards. This process includes evaluating experiences of all stakeholders (approximately 5 patient representatives, their significant others, and their clinicians per country) with the current care path, using both service design methods and the AI derived description of cancer patients experiences with their care paths from WP3. To address problems encountered, the care path is redesigned in a co-design process, involving all stakeholders; designers, patients and significant others, clinicians, and quality of care staff. A methodology and manual will be developed. Finally, clinicians and patients from DK, ES, NL will then create a Personal Care Path Navigator based upon the redesigned care path. In each of the 3 countries, this will be done for two patients for each of the two care paths that were redesigned in that country (so 12 patients in total). We will provide a training in shared decision making to the clinicians involved.
